Sign in

CIK 0000949858

  • Non-accelerated filer
  • Smaller reporting company

ACHIEVE LIFE SCIENCES, INC.

Sign in to watch
Tickers
ACHV QUIT
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
954343413
Phone
+1 425-686-1500
Business address
22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
Former names
ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC

Securities

  • ACHV Common stock Nasdaq
  • QUIT Common Shares Nasdaq
  1. 8-K Event Shareholder vote results
  2. 10-Q Report Quarterly Report
  3. 8-K Event Results of operations
  4. 8-K Event Material agreement · Bylaws or fiscal year change · Other events
  5. 8-K Event Executive or director change · Bylaws or fiscal year change · Shareholder vote results · Other events
  6. 10-Q/A Report 10-Q/A
  7. 10-Q Report Quarterly Report
  8. 8-K Event Results of operations
  9. 10-K Report Annual Report
  10. 8-K Event Results of operations
  11. 8-K Event Regulation FD disclosure
  12. 8-K Event Material agreement · Director nominations · Regulation FD disclosure
  13. 8-K Event Material agreement
  14. 10-Q Report Quarterly Report
  15. 8-K Event Results of operations
  16. 8-K Event Bylaws or fiscal year change · Shareholder vote results
  17. 8-K Event Material agreement
  18. 8-K Event Regulation FD disclosure
  19. 8-K Event Acquisition or sale completed · Shareholder rights changed · Auditor change · Change in control · Executive or director change · Bylaws or fiscal year change · Shareholder vote results
  20. 10-Q Report Quarterly Report

Page 7 of 21 · 404 filings